Tax planning for neurosurgeons with high W-2 + ASC K-1

Neurosurgery W-2 + ASC equity is one of the densest income mixes in medicine. Here’s the tax structure.

The financial trajectory of a neurosurgeon is unique. It’s not just a high W-2. For many, it’s a complex blend of salary from a hospital or large group, partnership distributions from the practice, and K-1 income from an Ambulatory Surgery Center (ASC) or other ancillary ventures. This isn’t a linear progression; it’s a multi-layered capital structure that, if managed poorly, can lead to a staggering tax bill. Most of us learn this the hard way—by seeing the seven-figure income on paper and the shockingly smaller number that actually hits our bank accounts after taxes.

The standard financial advice often fails at this level. The strategies that work for a primary care physician with a simple W-2 are insufficient for a surgeon-partner with multiple, interconnected income streams. This article breaks down the five core tax-planning pillars that are essential for neurosurgeons navigating this high-income, high-complexity environment. These are the conversations you should be having with your financial team. For a broader look at financial and operational guides, you can explore the neurosurgery free tools hub.

Deconstructing Your ASC K-1: Active vs. Passive Income

For many neurosurgeons in private practice, the biggest shift in financial complexity comes with buying into an Ambulatory Surgery Center. Your income is no longer just a salary; you’re now a business owner receiving a Schedule K-1. This single form fundamentally changes your tax picture, and misunderstanding its nuances is a common and costly mistake.

A K-1 reports your share of the ASC partnership’s income, losses, deductions, and credits. The critical distinction the IRS makes is whether your involvement is “active” or “passive.” This is governed by the material participation tests under Internal Revenue Code §469. If you spend significant, regular, and continuous time in the ASC’s operations—which, as a performing surgeon and partner, you almost certainly do—your income and losses are generally considered active.

Here’s why that matters:

• Active Income/Losses: Active losses from the ASC (common in the early years due to startup costs and depreciation) can typically be used to offset your other active income, including your W-2 salary from the surgical practice. This can create a powerful, immediate tax shield.
• Passive Income/Losses: If you were a silent, non-participating investor, your losses would be passive. Passive losses can only offset passive income (e.g., from other rental properties or businesses you don’t manage), not your active surgical income. The unused passive losses are suspended and carried forward.

The Planning Trap to Avoid: Basis and At-Risk Limitations.
A common pitfall is assuming a large K-1 loss automatically translates into a large tax deduction. You can only deduct losses up to your “basis” and “at-risk” amount in the partnership. Your basis is essentially your investment in the ASC—the cash you put in, plus your share of partnership debt for which you are personally liable. If your K-1 shows a $100,000 loss but your basis is only $50,000, you can only deduct $50,000 that year. The rest is suspended. When you structure your buy-in, understanding how it’s financed (cash vs. debt) is crucial for determining your initial basis and your ability to utilize early-year losses.

The 199A QBI Deduction: A Warning for High-Income Surgeons

The Qualified Business Income (QBI) deduction, established under Section 199A of the tax code, was one of the most talked-about provisions of the Tax Cuts and Jobs Act. It offers a potential 20% deduction on income from pass-through businesses like partnerships and S-corps. When surgeons first hear about it, they see a path to deducting 20% of their massive practice income. Unfortunately, for almost every practicing neurosurgeon, this is a mirage.

The deduction is severely limited for anyone in a “Specified Service Trade or Business” (SSTB). The tax code is explicit: the field of medicine is an SSTB. This means that once your taxable income exceeds certain thresholds, the QBI deduction begins to phase out and then disappears entirely.

For 2026, those thresholds are projected to be around $394,000 for single filers and $787,000 for those married filing jointly. A neurosurgeon’s income, especially when combined with a spouse’s, will almost invariably sail past the upper limit of this phase-out range. The result: your QBI deduction on your surgical practice and ASC income is zero.

The Planning Trap to Avoid: Chasing a Ghost.
The trap here isn’t a complex rule; it’s a strategic misallocation of effort. I’ve seen physicians and their advisors spend hours trying to structure things to “qualify” for QBI, such as creating separate management companies or other complex schemes that the IRS often views with suspicion. This is wasted energy. For a high-earning surgeon, the reality is that the QBI deduction is off the table for your medical income. The correct strategic response is to accept this and pivot your focus to more powerful and reliable strategies that are actually available to you, like the ones that follow.

The Medical Real Estate Lease-Back: Your Personal Tax Arbitrage

One of the most effective tax strategies for a physician group is to own the real estate where you practice. This is typically done by forming a separate entity, usually a multi-member LLC, to purchase the medical office building or ASC facility. This LLC then leases the property back to your medical practice at a fair market rate.

This structure creates a powerful form of tax arbitrage:

1. The Practice (Lessee): Your surgical practice pays rent to the real estate LLC. This rent is a fully deductible business expense, reducing the practice’s taxable income.
2. The Real Estate LLC (Lessor): The LLC receives this rental income. However, this income is offset by the expenses of owning the building: mortgage interest, property taxes, insurance, and—most importantly—depreciation.

This effectively shifts income from your medical practice, which could be subject to higher tax rates and self-employment taxes, to a real estate entity where it can be sheltered by non-cash deductions like depreciation. The goal is often to create a paper loss on the real estate entity, even while it generates positive cash flow.

The Planning Trap to Avoid: Passive Loss Limitations (and the REPS Solution).
By default, rental real estate is considered a passive activity. As we discussed with the ASC K-1, this means any losses generated by the real estate LLC can typically only offset other passive income. They can’t be used to offset your high W-2 surgical income.

This is where Real Estate Professional Status (REPS) becomes a game-changer, particularly for your non-physician spouse. If your spouse can qualify for REPS and you file a joint tax return, the rental losses from your medical real estate (and any other rentals you own) become non-passive. They can be used to directly offset your active surgical income. To qualify, your spouse must spend more than 750 hours per year and more than 50% of their total working time on real estate activities. This requires meticulous, contemporaneous time logs but can transform a paper loss into tens or even hundreds of thousands of dollars in direct tax savings. You can model out different scenarios with a real estate investing calculator to see the potential impact.

Supercharging Deductions with Cost Segregation Studies

Owning your medical real estate opens the door to another powerful strategy: cost segregation. When you buy a commercial building, the IRS typically requires you to depreciate it over a 39-year straight-line schedule. This means you get a small, steady depreciation deduction each year for nearly four decades. A cost segregation study shatters this timeline.

A cost segregation study is an engineering-based analysis that identifies and reclassifies components of your building into shorter depreciation categories. Instead of treating the entire building as one 39-year asset, it breaks it down:

• Land Improvements (15-year property): Parking lots, landscaping, sidewalks.
• Personal Property (5- or 7-year property): Specialty electrical wiring for medical equipment, dedicated plumbing, custom cabinetry, carpets, decorative lighting.

By reclassifying, say, 25% of the building’s cost from a 39-year life to a 5-year life, you can dramatically accelerate your depreciation deductions. Instead of waiting 39 years to write off that portion of the asset, you can write it off in just five. When combined with bonus depreciation (which has allowed for 100% first-year write-offs in recent years, though it’s now phasing down), this can generate a massive tax deduction in the year you purchase the property.

The Planning Trap to Avoid: DIY or Discount Studies.
The IRS is well aware of this strategy and scrutinizes it. A cost segregation study must be based on a credible engineering analysis, not a simple estimate or a rule-of-thumb percentage. Using a cheap, non-engineering-based online service is a red flag for an audit. A proper study involves a detailed review of blueprints, construction costs, and often a site visit. The cost of a quality study is a deductible business expense and is dwarfed by the tax savings it generates. This is not the place to cut corners. A physician-focused CPA can connect you with a reputable engineering firm that specializes in medical facilities.

The Ultimate Shelter: Stacking a Cash Balance Plan on Your 401(k)

For a high-earning neurosurgeon in their peak earning years (40s and 50s), the single most powerful pre-tax savings vehicle is a cash balance plan. This is a type of defined-benefit pension plan that allows for massive tax-deductible contributions, far exceeding the limits of a 401(k).

Most physicians are familiar with a 401(k) and its profit-sharing component, which allows for total contributions of around $69,000 (for 2024, indexed annually). A cash balance plan can be “stacked” on top of this. The contribution limits for a cash balance plan are not fixed; they are determined by an actuary based on your age, income, and other factors. It is not uncommon for a surgeon in their 50s to be able to contribute an additional $200,000, $250,000, or even over $300,000 per year into one of these plans.

Every dollar contributed is a direct, above-the-line deduction from your taxable income. A $250,000 contribution can easily translate into over $100,000 in combined federal and state tax savings in a single year. The funds grow tax-deferred, just like in a 401(k), and can be rolled over into an IRA upon retirement or separation from the practice.

The Planning Trap to Avoid: Inflexible Commitments and Employee Costs.
A cash balance plan is a formal pension plan subject to ERISA rules. This is not a “maybe” contribution. The practice is generally required to make the contribution calculated by the actuary each year. While there is some flexibility, it’s not like a 401(k) profit-sharing contribution that can be skipped in a down year. Furthermore, these plans must also cover eligible employees, and non-discrimination rules require that they receive a contribution as well, typically a percentage of their pay (e.g., 5-7.5%). This cost must be factored into the decision. However, for a practice with a small number of highly-paid surgeon-partners and a larger number of lower-paid staff, the vast majority of the tax-deductible contributions (often 90%+) will go to the partners, making the employee cost a very worthwhile trade-off for the massive personal tax deferral.

Navigating the intersection of a high W-2, ASC ownership, and sophisticated retirement planning requires a proactive and specialized approach. These strategies are not set-it-and-forget-it; they are interconnected parts of a dynamic financial structure. By understanding the mechanics of K-1s, the limitations of QBI, and the immense power of real estate and advanced retirement plans, you can move from simply earning a high income to strategically building and protecting long-term wealth.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026